These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9718627)

  • 1. Postmortem studies in schizophrenia.
    Powchik P; Davidson M; Haroutunian V; Gabriel SM; Purohit DP; Perl DP; Harvey PD; Davis KL
    Schizophr Bull; 1998; 24(3):325-41. PubMed ID: 9718627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical cholinergic markers in schizophrenia.
    Haroutunian V; Davidson M; Kanof PD; Perl DP; Powchik P; Losonczy M; McCrystal J; Purohit DP; Bierer LM; Davis KL
    Schizophr Res; 1994 May; 12(2):137-44. PubMed ID: 8043524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer's disease.
    Potter PE; Rauschkolb PK; Pandya Y; Sue LI; Sabbagh MN; Walker DG; Beach TG
    Acta Neuropathol; 2011 Jul; 122(1):49-60. PubMed ID: 21533854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological investigation of the background of cognitive decline in elderly schizophrenia.
    Miwa A; Hirano M; Torii Y; Sekiguchi H; Habuchi C; Fujishiro H; Yoshida M; Iwai K; Kawashima K; Iritani S
    Acta Neuropsychiatr; 2021 Apr; 33(2):85-91. PubMed ID: 33143788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study.
    Purohit DP; Davidson M; Perl DP; Powchik P; Haroutunian VH; Bierer LM; McCrystal J; Losonczy M; Davis KL
    Biol Psychiatry; 1993 Feb; 33(4):255-60. PubMed ID: 8471678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right-hemisphere encephalopathy in elderly subjects with schizophrenia: evidence from neuropsychological and brain imaging studies.
    Gabrovska-Johnson VS; Scott M; Jeffries S; Thacker N; Baldwin RC; Burns A; Lewis SW; Deakin JF
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):367-75. PubMed ID: 12845412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation].
    Dubois B; Hauw JJ; Ruberg M; Serdaru M; Javoy-Agid F; Agid Y
    Rev Neurol (Paris); 1985; 141(3):184-93. PubMed ID: 4001706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased mesopontine choline acetyltransferase levels in schizophrenia. Correlations with cognitive functions.
    Karson CN; Mrak RE; Husain MM; Griffin WS
    Mol Chem Neuropathol; 1996; 29(2-3):181-91. PubMed ID: 8971695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the neuropathology of schizophrenia and its dementia: neurodevelopmental, neurodegenerative, or both?
    Harrison PJ
    Neurodegeneration; 1995 Mar; 4(1):1-12. PubMed ID: 7600178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychopathology of schizophrenia and brain imaging].
    Gross G; Huber G
    Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S49-56. PubMed ID: 18461545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex.
    Gabriel SM; Davidson M; Haroutunian V; Powchik P; Bierer LM; Purohit DP; Perl DP; Davis KL
    Biol Psychiatry; 1996 Jan; 39(2):82-91. PubMed ID: 8717605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment in elderly schizophrenia: a dementia (still) lacking distinctive histopathology.
    Arnold SE; Trojanowski JQ
    Schizophr Bull; 1996; 22(1):5-9. PubMed ID: 8685663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical dopamine in schizophrenia: strategies for postmortem studies.
    Lewis DA; Akil M
    J Psychiatr Res; 1997; 31(2):175-95. PubMed ID: 9278185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease.
    Tsang SW; Lai MK; Kirvell S; Francis PT; Esiri MM; Hope T; Chen CP; Wong PT
    Neurobiol Aging; 2006 Sep; 27(9):1216-23. PubMed ID: 16129514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer-type neuropathology in elderly schizophrenia patients.
    Prohovnik I; Dwork AJ; Kaufman MA; Willson N
    Schizophr Bull; 1993; 19(4):805-16. PubMed ID: 8303229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques.
    Katzman R; Terry R; DeTeresa R; Brown T; Davies P; Fuld P; Renbing X; Peck A
    Ann Neurol; 1988 Feb; 23(2):138-44. PubMed ID: 2897823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo neuropathology of cortical changes in elderly persons with schizophrenia.
    Frisoni GB; Prestia A; Adorni A; Rasser PE; Cotelli M; Soricelli A; Bonetti M; Geroldi C; Giannakopoulos P; Thompson PM
    Biol Psychiatry; 2009 Sep; 66(6):578-85. PubMed ID: 19409532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galanin immunoreactivity is increased in the nucleus basalis of Meynert in Alzheimer's disease.
    Beal MF; MacGarvey U; Swartz KJ
    Ann Neurol; 1990 Aug; 28(2):157-61. PubMed ID: 1699471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choline acetyltransferase in schizophrenia.
    Karson CN; Casanova MF; Kleinman JE; Griffin WS
    Am J Psychiatry; 1993 Mar; 150(3):454-9. PubMed ID: 8434662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine-Related Disruption of Functional Topography of Striatal Connections in Unmedicated Patients With Schizophrenia.
    Horga G; Cassidy CM; Xu X; Moore H; Slifstein M; Van Snellenberg JX; Abi-Dargham A
    JAMA Psychiatry; 2016 Aug; 73(8):862-70. PubMed ID: 27145361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.